OMS-1620

N/A

Report date: 2025/07/18 14:26:36
NME

Base Information

Drug NameOMS-1620
Drug Alias NameOMS-1620
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 2 antagonists
TargetsMelanocortin receptor 2
Therapy Area/IndicationsAdrenal Hyperplasia, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOMass Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOMass Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsAdrenal Hyperplasia, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A